JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)

Market Cap	11.61B +3.2%
Revenue (ttm)	2.23B +10.8%
Net Income	617.04M +10.7%
EPS	1.42 +10.9%
Shares Out	435.17M
PE Ratio	18.79
Forward PE	n/a
Dividend	0.68 (2.55%)
Ex-Dividend Date	Jun 17, 2025

Volume	423,100
Average Volume	1,124,872
Open	26.10
Previous Close	26.30
Day's Range	26.00 - 26.70
52-Week Range	25.63 - 30.86
Beta	0.44
RSI	44.43
Earnings Date	Apr 24, 2026

About SHA:603235

JiangXi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. The company offers products of vitamin B6, vitamin B1, Vitamin D3, pyridoxine hydrochloride CD grade, thiamine nitrate DC grade, folic acid, biotin, ascorbyl palmitate, vitamin E 500, α-acetyl-γ-butyrolactone, and vitamin D3 for use as bulk pharmaceutical chemicals, API, food additives, and feed additives, as well as in other fields. JiangXi Tianxin Pharmaceutical Co., Ltd. was founded in 2004 and is based in Leping, China.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 2004
• Employees: 2,679
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603235

Financial Performance

In 2024, SHA:603235's revenue was 2.21 billion, an increase of 17.35% compared to the previous year's 1.88 billion. Earnings were 651.22 million, an increase of 36.85%.